Skip to content
- aflibercept (Zaltrap®)
- axitinib (Inlyta®)
- bevacizumab (Avastin®)
- cabozantinib (Cabometyx®)
- regorafenib (Stivarga®)
- sorafenib (Nexavar®)
- sunitinib (Sutent®)
- alectinib (Alecensa®)
- brigatinib (Alunbrig®)
- ceritinib (Zykadia®)
- crizotinib (Xalkori®)
- lorlatinib (Lorviqua®)
- rucaparib (Rubraca®)
- pertuzumab (Perjeta®)
- T-DM1/ trastuzumab emtansine (Kadcyla®)
- trastuzumab (Herceptin®)
- abemaciclib (Verzenios®)
- palbociclib (Ibrance®)
- ribociclib (Kisqali®)
- dabrafenib (Tafinlar®)
- encorafenib (Braftovi®)
- niraparib (Zejula®)
- olaparib (Lynparza®)
- binimetinib (Mektovi®)
- cobimetinib (Cotellic®)
- trametinib (Mekinist®)
- evérolimus (Afinitor®)
- temsirolimus (Torisel®)